Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HMA
HEALTH MGMT ASSOC INC CL-A
HMA
|
+$105M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$86.2M |
| 3 |
ELN
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
|
+$78.8M |
| 4 |
Bank of America
BAC
|
+$73.8M |
| 5 |
CTB
Cooper Tire & Rubber Co.
CTB
|
+$64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$112M |
| 2 |
Zoetis
ZTS
|
+$95.2M |
| 3 |
Ameriprise Financial
AMP
|
+$71.8M |
| 4 |
CLWR
CLEARWIRE CORP NEW CL A COM STK (DE)
CLWR
|
+$67.1M |
| 5 |
Citigroup
C
|
+$65.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.44% |
| 2 | Healthcare | 12.84% |
| 3 | Technology | 12.15% |
| 4 | Consumer Discretionary | 9.87% |
| 5 | Industrials | 8.85% |
Similar funds
Cliff Asness's Q3 2013 Portfolio in Review
As of Q3 2013, Cliff Asness held 2,633 positions worth $28.4B, up 0.7% from $28.2B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Cliff Asness withdrew a net $3.1B in Q3 2013, closing 162 positions and reducing 1,040 holdings. Its most notable exit was CLEARWIRE CORP NEW CL A COM STK (DE), an estimated $67.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Cliff Asness opened a new position in Twenty-First Century Fox, Inc. Class A worth $91.7M.
- Cliff Asness's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,736,469 shares worth $91.7M.
- Cliff Asness added most to HEALTH MGMT ASSOC INC CL-A in Q3 2013, an estimated $105M increase.
- Cliff Asness's biggest Q3 2013 reduction was Pfizer, cutting an estimated $112M.
- Cliff Asness fully exited CLEARWIRE CORP NEW CL A COM STK (DE) in Q3 2013, selling an estimated $67.1M.
- Cliff Asness's ten largest holdings make up 8.2% of its $28.4B portfolio in Q3 2013.
- Cliff Asness opened 316 new positions and closed 162 in Q3 2013.
- Cliff Asness's portfolio value rose 0.7% quarter-over-quarter to $28.4B.
Based on AQR Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.